Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

BTIG Research assumed coverage on shares of V2X (NYSE:VVX – Free Report) in a research note issued to investors on Monday ...

Fintel reports that on November 27, 2024, BTIG upgraded their outlook for Embecta (NasdaqGS:EMBC) from Neutral to Buy. Analyst Price Forecast Suggests 20.45% Downside As of November 21, 2024, the ...

Oil (CL1:COM) prices and the broader energy sector have been among the worst-performing areas of the economy since the start ...

BTIG analyst Gray Powell raised the firm’s price target on Zscaler (ZS) to $238 from $205 and keeps a Buy rating on the shares. The firm’s ...

Specialty Finance Analyst Caintic holds a meeting with CEO Howard and CFO McCamey in Boston on December 4 hosted by BTIG.Don't Miss our Black ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 results. Read more here.

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at ...

Alector (NASDAQ:ALEC – Free Report) had its target price lowered by BTIG Research from $16.00 to $5.00 in a research note ...

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced Nick Curtis, ...

Event: 4 th Annual BTIG Ophthalmology Day Participant: Dr. Gary S. Jacob, CEO of OKYO Pharma For more information about the ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable ...